DDI Cards - Czech version

ESGO eAcademy, Faculty / Presenter(s), 4152480

DDI - Vaginal cancer

ESGO eAcademy, Faculty / Presenter(s), 4152478

DDI Cards - Hebrew version

ESGO eAcademy, Faculty / Presenter(s), 4152484

DDI Cards - Russian version

ESGO eAcademy, Faculty / Presenter(s), 4152483

DDI Cards - Finnish version

ESGO eAcademy, Faculty / Presenter(s), 4152482

DDI Cards - Spanish version

ESGO eAcademy, Faculty / Presenter(s), 4152481

Invitation to ESGO 2026 in Copenhagen

ESGO eAcademy, Mansoor Raza Mirza, 4151886

ESGO 2025 Congress Summary

ESGO eAcademy, Anna Fagotti, 4151884

Discussant at Best Oral Session - Cervical cancer

ESGO eAcademy, Maria Kyrgiou, 4151874

Comparison Of Hybrid Capture 2 Oncogenic HPV Test Performance On Evalyn- Vs Qiagen-Brush Self-Collected Specimens Among A South African Population Enriched For HIV-Positivity

ESGO eAcademy, Greta Dreyer, 4151873

Interactive Exploration of ChatGPT: 4 Case Studies

ESGO eAcademy, Frederic Amant, 4151883

Interactive Exploration of ChatGPT: 4 Case Studies

ESGO eAcademy, Christian Marth, 4151882

Discussant: Best oral session - Cervical Cancer

ESGO eAcademy, Remi Nout, 4151872

Potential Challenges for Future Surgical Trials

ESGO eAcademy, Anna Fagotti, 4151877

Patient-Reported Outcomes With Pembrolizumab Plus Chemoradiotherapy For High-Risk, Locally Advanced Cervical Cancer: Interim Analysis 2 Results From The Randomised, Double-Blind, Phase 3 ENGOT-Cx11/GOG-3047/KEYNOTE-A18 Study

ESGO eAcademy, Vladyslav Sukhin, 4151871

How to Use Natural Language Processing and ChatGPT in a Clinical Setting

ESGO eAcademy, Sander Puts, 4151881

Relevant Questions Addressed by Ongoing Surgical Trials

ESGO eAcademy, Aleksandra Strojna, 4151876

A Single-Arm, Multicenter, Phase II Study On Carboplatin-Paclitaxel-Pembrolizumab In Neoadjuvant Treatment Of Locally Advanced Cervical Cancer: The MITO CERV3 Study

ESGO eAcademy, Domenica Lorusso, 4151870

Artificial Intelligence and the Future in the Surgical Theatre

ESGO eAcademy, Andrea Rosati, 4151880

Notable Surgical Trials in Gynecologic Oncology: A 10-year Overview

ESGO eAcademy, Gretchen Glaser, 4151875

Academic Randomized Phase II Trial Assessing The Inhibitor Of Programmed Cell Death Ligand 1 (PD-L1) Immune Checkpoint Atezolizumab In Combination With Chemoradiation In Locally Advanced Cervical Cancer (ATEZOLACC Trial)

ESGO eAcademy, Cyrus Chargari, 4151869

The Importance of Medical Guidelines for Non-Professionals

ESGO eAcademy, Vesna Bondžic, 4151865

A Step-By-Step Technique For VNOTES Pelvic Lymphadenectomy In Early-Stage Endometrial Cancer

ESGO eAcademy, Sanha Lee, 4151861

Interdisciplinary Collaborations Aimed at Developing Sustainable Healthcare Technologies - The green OR

ESGO eAcademy, Frank Willem Jansen, 4151868

Care of HIV Positive Patients

ESGO eAcademy, Anisa Mburu, 4151864

Use Of Indocyanine Green For Intraoperative Ureteral Identification In Difficult Hysterectomies For Gynecologic Malignancies.

ESGO eAcademy, Francesca Falcone, 4151860

Pelvic Anatomy

ESGO eAcademy, Selcuk Erkilinc, 4151859

The Impact of Screening Programs on Carbon Footprint: Is Prevention the Most Effective Way?

ESGO eAcademy, Joanna Kacperczyk-Bartnik, 4151867

Highlights of ESGO’s First RSG on Cervical Cancer

ESGO eAcademy, Basel Refky, 4151863

Vascular Reconstruction After Resection Of Vena Cava For Recurrent Endometrial Cancer

ESGO eAcademy, Michal Zikan, 4151858

Environmental Impact of Gynaecologic Oncology Practice: How We Need to Evaluate and to Improve Our Practices

ESGO eAcademy, Thomas Gaillard, 4151866

RSG - A New Format Not Only for Developing Countries

ESGO eAcademy, David Cibula, 4151862

Cytoreduction And Partial Cystectomy In Advanced Endometrial Cancer Performed By Robotic Assisted Surgery

ESGO eAcademy, Juan Carlos Torrejon Becerra, 4151857

The Role Of Hyperthermia In Intraperitoneal Chemotherapy On Abdominal Tissue Concentrations Of Cisplatin: Insights From A Porcine Model

ESGO eAcademy, Christina Harlev, 4151848

Role Of Radiomics Applied To Ultrasound In Patients With Locally Advanced Cervical Cancer: A Retrospective Multicenter Study (RU-LACC Study).

ESGO eAcademy, Camilla Culcasi, 4151847

Racial Disparities In Clinical Characteristics And Survival Of Vulvar Cancer Across Histological Subtypes: A Population-Based Cohort Study

ESGO eAcademy, Penglin Liu, 4151846

Current Aspects of the Follow-Up Care of Elderly Ppatients with Gynaecological Malignancies?

ESGO eAcademy, Maja Pakiz, 4151839

Novel Techniques: New Trials on SLN and Surgical Approach

ESGO eAcademy, Nicolo Bizzarri, 4151836

Postvoid Residual Volume Control After Radical Hysterectomy For Early Cervical Cancer

ESGO eAcademy, Naia Seminario, 4151844

Urine High Risk Human Papillomavirus Testing As An Alternative Cervical Screening Strategy: The ACES Studies

ESGO eAcademy, Jennifer Davies, 4151843

Perioperative Management of Elderly Patients

ESGO eAcademy, Jalid Sehouli, 4151838

Surgical Approach for Staging in Early-stage Ovarian Cancer and Surgical Steps for Para-aortic Lymphadenectomy

ESGO eAcademy, Ane Gerda Eriksson, 4151835

The Silva Pattern-Based Classification And Oncological Outcomes In Women Undergoing Fertility-Sparing Surgery For Early-Stage Cervical Cancer

ESGO eAcademy, Kristine Hagen, 4151842

STOMa-LeAk Ratio In Advanced Ovarian Cancer Surgery: Results Of A Restrictive Policy On The Use Of Protective Stomas

ESGO eAcademy, Virginia Vargiu, 4151841

Molecular Predictors Of Chemo-Radioresistance And Their Changes During Chemoradiation With And Without Modulated Electrohyperthermia (Oncothermia) In Patients With Locally Advanced Cervical Cancer IIb-IVa FIGO.

ESGO eAcademy, Sapiiat Isaeva, 4151840

How Do We Describe Elderly and Frailty in Our Trials?

ESGO eAcademy, Lara Maria Stričak, 4151837

Indications for Staging/Re-staging in Early-stage Ovarian Cancer

ESGO eAcademy, Martina Angeles Fite, 4151834

Conclusion

ESGO eAcademy, Nicoletta Colombo, 4151833

Data to Decision: Navigating Treatment Options and Strategy to Optimise Treatment Outcome for Patients with Newly Diagnosed Advanced Ovarian Cancer

ESGO eAcademy, Nicoletta Colombo, 4151830

Overview of the Latest Long-Term Survival Data from First-Line PARPi Trials

ESGO eAcademy, Isabelle Ray-Coquard, 4151829

Welcome and Introduction

ESGO eAcademy, Nicoletta Colombo, 4151828

Discussant - SUROVA Study Global Real-World Treatment Strategies And Mortality Risk PredictionIn Advanced Ovarian Cancer

ESGO eAcademy, Dennis Chi, 4151818

Spatial Integration of Medical Imaging and Computational Pathology for Tumour Heterogeneity Mapping in Ovarian Cancer

ESGO eAcademy, Konstantinos Zormpas-Petridis, 4151821

SUROVA Study: Global Real-World Treatment Strategies And Mortality Risk Prediction In Advanced Ovarian Cancer

ESGO eAcademy, Luis Chiva, 4151817

Which Agents Are on the Horizon? Addressing Homologous Recombination Proficiency in Ovarian Cancer

ESGO eAcademy, Ilaria Colombo, 4151813

Discussant - Late Breaking Ovarian Cancer

ESGO eAcademy, Christian Marth, 4151816

Innovations in AI and Gynaecologic Oncology Surgery

ESGO eAcademy, Houssein El Hajj, 4151820

Molecular Mechanisms of Primary and Acquired PARP Inhibitor Resistance

ESGO eAcademy, Iain McNeish, 4151812

Randomized Phase II/III Trial Of 3 Vs 6 Courses Of Neoadjuvant Carboplatin-Paclitaxel Chemotherapy In Stage IIIC Or IV Epithelial Ovarian, Fallopian Tube Or Primary Peritoneal Carcinoma

ESGO eAcademy, Claudio Zamagni, 4151815

Implementation of AI-Driven Support for Ovarian Cancer Ultrasound Diagnostics

ESGO eAcademy, Elisabeth Epstein, 4151819

Chemotherapy With Or Without Pembrolizumab Followed By Maintenance With Olaparib Or Placebo For First-Line Treatment Of Advanced BRCA Non-Mutated Epithelial Ovarian Cancer: Results From The Randomized Phase 3 ENGOT-OV43/GOG-3036/KEYLYNK-001 Study

ESGO eAcademy, Ignace Vergote, 4151814

Interactive Discussion: Optimizing Advanced & Recurrent Endometrial Cancer Management

ESGO eAcademy, Shannon Westin, 4151803

Understanding the Complexity of Advanced & Recurrent Endometrial Cancer Disease and Treatment Landscape

ESGO eAcademy, Shannon Westin, 4151798

Welcome and Introduction

ESGO eAcademy, Ramez Eskander, 4151797

Sexual Dysfunction And Body Image In BRCA Mutation Carriers Before And After Prophylactic Salpingo - Oophorectomy: A Cross-Sectional Study

ESGO eAcademy, Elisa Farsi, 4151795

Genomics of STIC Lesions and Risk of Subsequent High Grade Serous Carcinoma

ESGO eAcademy, Iain McNeish, 4151789

Efficacy And Safety Of Intravenous Administration Of High-Dose Selenium For Preventing Chemotherapy-Induced Peripheral Neuropathy In Platinum-Sensitive Recurrent Ovarian, Fallopian Or Primary Peritoneal Cancer: Study Protocol For A Phase III, Double-Blind, Randomized Study

ESGO eAcademy, Ga Won Yim, 4151794

Safety Of Topical Estrogen Therapy During Adjuvant Endocrine Treatment Among Patients With Breast Cancer: A Meta-Analysis Based Expert Panel Discussion

ESGO eAcademy, Stavroula Kastora, 4151793

PRO Radical Hysterectomy

ESGO eAcademy, David Cibula, 4151786

Pathology of STIC Lesions

ESGO eAcademy, Sigurd Lax, 4151788

Radiomics-Based Ultrasound Model For Differentiating Uterine Sarcomas From Leiomyomas: The ROMUS Study In The MITO Group

ESGO eAcademy, Alessandra Rizzi, 4151792

Efficacy Of A Multi-Ingredient Coriolus Versicolor-Based Vaginal Gel On High-Risk HPV Clearance: Final Results From The PALOMA 2 Clinical Trial.

ESGO eAcademy, Damián Dexeus Carter, 4151790

Surgical Management of STIC – Strategies for Risk-reducing Surgery

ESGO eAcademy, Claudia Marchetti, 4151787

PRO Total Mesometrial Resection

ESGO eAcademy, Henrik Falconer, 4151785

Efficacy Of Transvaginal Ultrasound To Visualize The Colorectal Anastomosis And Its Integrity In An Ovarian Cancer Patients Undergoing Cytoreductive Surgery With Recto-Sigmoid Resection.

ESGO eAcademy, Chiara Caricato, 4151770

Protecting Vaginal Health: Practical Strategies after Gynaecological Cancer Treatment

ESGO eAcademy, Richard Gabor Toth, 4151777

Complete Pelvic Peritonectomy With Extraperitoneal Hysterectomy With Or Without En-Bloc Rectal Resection

ESGO eAcademy, Lana Bijelic, 4151769

3D-Reconstruction and Laparoscopic Liver Resection for Recurrent Ovarian Cancer: Quaternary Cytoreductive Surgery

ESGO eAcademy, Valerio Gallotta, 4151768

ADCs Safety Profile: How to Identify Their AEs and How to Manage

ESGO eAcademy, Angelica Rodrigues, 4151773

Empowering Care: The Mallow Flower Collaborative Approach to Sexual Health Education and Support

ESGO eAcademy, Icó Tóth, 4151776

Surgical Resection Of A Hepato-Gastric Recurrence Of A High Grade Serous Ovarian Cancer

ESGO eAcademy, Giulio Ricotta, 4151767

A Paradigm Shift in the Treatment of Gyn Tumours: ADCs

ESGO eAcademy, Antonio Gonzalez Martin, 4151772

Mapping Patient Needs: Insights and Actions from Sexual Health Survey in Gynaecologic Oncology

ESGO eAcademy, Zoia Razumova, 4151775

Transvaginal Natural Orifice Transluminal Endoscopic Surgery (VNOTES) Pelvic, Para-Aortic Lymph Node Dissection and Omentectomy via Transperitoneal Approach in Patient with Ovarian Cancer

ESGO eAcademy, Rabia Merve Palalioglu, 4151766

Ultrasound Assessment of Lymph Nodes for Staging of Gynecological Cancer: Consensus Opinion on Terminology and Examination Technique

ESGO eAcademy, Elena Gatti, 4151765

Delving into ADCs Structure and Mechanism of Action

ESGO eAcademy, Toon Van Gorp, 4151771

Reclaiming Intimacy: The Patient Journey Through Sexual Health During and After Gynaecologic Cancer Treatment

ESGO eAcademy, Kim Hulscher, 4151774

PSOGI-ESGO-ISSPP Consensus on Peritonectomy Procedures

ESGO eAcademy, Artem Stepanyan, 4151764

SHR-2004, A Novel Humanised Monoclonal Antibody Targeting Factor XI (FXI), For Preventing Venous Thromboembolism (VTE) In Patients Undergoing Surgery For Ovarian Cancer: A Randomised, Active-Control Phase 2 Study

ESGO eAcademy, Jianqing Zhu, 4151760

Prospective Assessment Of The Association Between Perioperative Fluid Balance And Postoperative Complications After Surgery For Advanced Ovarian Cancer; Ancillary Data From A Randomised Controlled Trial

ESGO eAcademy, Sahar Salehi, 4151759

Effect Of Crossover-Surgery At The Subsequent Relapse On The Survival Of Patients With Platinum-Sensitive Relapsed Ovarian Cancer: Prespecified And Post-Hoc Analyses Of The SOC-1 Randomized Phase 3 Trial

ESGO eAcademy, Yulian Chen, 4151758

Case Presentation - Endometrial cancer challenges

ESGO eAcademy, Olfa Jaidane, 4151763

Which Systemic Therapies are Indicated?

ESGO eAcademy, Angelica Rodrigues, 4151752

Stereotactic Ablative Radiotherapy for Oligometastatic Ovarian Cancer Parenchymal Disease: The MITO-RT3/RAD Phase II Trial

ESGO eAcademy, Gabriella Macchia, 4151757

Updated Patient-Reported Outcomes In The PRIMA/ENGOT-OV26/GOG-3012 Trial Of Niraparib First-Line Maintenance Therapy In Patients With Newly Diagnosed Advanced Ovarian Cancer

ESGO eAcademy, Domenica Lorusso, 4151756

Challenging Settings Facing Endometrial Cancer Tumour Boards in Limited Resources Settings

ESGO eAcademy, Basel Refky, 4151762

When are RT and Ablative Therapies Indicated?

ESGO eAcademy, Alina Sturdza, 4151751

Efficacy Of Secondary Cytoreductive Surgery In Recurrent Low-Grade Serous Ovarian Cancer: A Multicenter Retrospective Analysis

ESGO eAcademy, Thomas Gaillard, 4151755

Impact Of Ascites And Peritoneal Metastatic Lesion Volumes, Measured By Newly Developed Deep Learning-Based Algorithm, In Advanced Epithelial Ovarian Cancer

ESGO eAcademy, Se Ik Kim Kim, 4151754

Challenging Settings Facing Cervical Cancer Tumour Boards in Limited Resources Settings, 8 Years Experience

ESGO eAcademy, Olga P. Matylevich, 4151761